CNS Oncology Archives - Oncology Central Oncology Central

A new NHS study has demonstrated the benefit of assessing tumor mutations in #PediatricCancer, giving them the potential to receive treatments usually reserved for adult cancers. https://t.co/BHIBFzIQH5

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

Intracranial meningioma with carcinoma tumor-to-tumor metastasis: two case reports

Does Graded Prognostic Assessment outperform Recursive Partitioning Analysis in patients with moderate prognosis brain metastases?

Fatigue among patients with brain tumors

Does valproic acid affect tumor growth and improve survival in glioblastomas?

Genetic biomarkers of drug response for small-molecule therapeutics targeting the RTK/Ras/PI3K, p53 or Rb pathway in glioblastoma

Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review

Personalized medicine in neuro-oncology

In Focus: lung cancer

Neuro-oncology family caregiving: review and directions for future research

Wnt signaling and astrocytic brain tumors

Assessing and monitoring intratumor heterogeneity in glioblastoma: how far has multimodal imaging come?

Stereotactic radiosurgery alone for limited brain metastases: are we ready for prime time?

Late relapses in primary CNS lymphoma after complete remissions with high-dose methotrexate monotherapy

To what extent will 5-aminolevulinic acid change the face of malignant glioma surgery?

Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics

Spine metastases: are minimally invasive surgical techniques living up to the hype?

Managing teenage/young adult (TYA) brain tumors: a UK perspective

Management of CNS germinoma

Assessing MGMT methylation status and its current impact on treatment in glioblastoma

Is there any role for stereotactic body radiotherapy in the management of metastatic epidural spinal cord compression?

Brain metastases: an overview

Diagnosis of pseudoprogression using MRI perfusion in patients with glioblastoma multiforme may predict improved survival

Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy

Stem cell niche irradiation in glioblastoma: providing a ray of hope?

Login

CNS Oncology

Must read